Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen

G. C. Kudva; M. Chandy; D. Dennison; A. Srivastava; V. Bhushan

Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen

G. C. Kudva^*, M. Chandy, D. Dennison, A. Srivastava, V. Bhushan

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Sixty-two adults with acute lymphoblastic leukaemia (ALL) were treated with a modified BFM regimen. Forty-two (70%) achieved complete remission (CR). Twenty-two percent of all evaluable patients and 32.4 percent of complete responders are in continuous complete remission (CCR) at a median follow-up of 41 months (range 24-81 months). Long-term survival was better in T- ALL (47.1%) when compared to precursor-B ALL (4.8%) (P < 0.04).

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	Indian Journal of Cancer
Volume	31
Issue number	1
Publication status	Published - 1994
Externally published	Yes

ASJC Scopus subject areas

Oncology

Cite this

@article{48ff8ed4e694432fa0aa5401b86a8684,

title = "Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen",

abstract = "Sixty-two adults with acute lymphoblastic leukaemia (ALL) were treated with a modified BFM regimen. Forty-two (70%) achieved complete remission (CR). Twenty-two percent of all evaluable patients and 32.4 percent of complete responders are in continuous complete remission (CCR) at a median follow-up of 41 months (range 24-81 months). Long-term survival was better in T- ALL (47.1%) when compared to precursor-B ALL (4.8%) (P < 0.04).",

author = "Kudva, {G. C.} and M. Chandy and D. Dennison and A. Srivastava and V. Bhushan",

year = "1994",

language = "English",

volume = "31",

pages = "1--7",

journal = "Indian Journal of Cancer",

issn = "0019-509X",

publisher = "Medknow Publications and Media Pvt. Ltd",

number = "1",

}

TY - JOUR

T1 - Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen

AU - Kudva, G. C.

AU - Chandy, M.

AU - Dennison, D.

AU - Srivastava, A.

AU - Bhushan, V.

PY - 1994

Y1 - 1994

N2 - Sixty-two adults with acute lymphoblastic leukaemia (ALL) were treated with a modified BFM regimen. Forty-two (70%) achieved complete remission (CR). Twenty-two percent of all evaluable patients and 32.4 percent of complete responders are in continuous complete remission (CCR) at a median follow-up of 41 months (range 24-81 months). Long-term survival was better in T- ALL (47.1%) when compared to precursor-B ALL (4.8%) (P < 0.04).

AB - Sixty-two adults with acute lymphoblastic leukaemia (ALL) were treated with a modified BFM regimen. Forty-two (70%) achieved complete remission (CR). Twenty-two percent of all evaluable patients and 32.4 percent of complete responders are in continuous complete remission (CCR) at a median follow-up of 41 months (range 24-81 months). Long-term survival was better in T- ALL (47.1%) when compared to precursor-B ALL (4.8%) (P < 0.04).

UR - http://www.scopus.com/inward/record.url?scp=0028041607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028041607&partnerID=8YFLogxK

M3 - Article

C2 - 8063329

AN - SCOPUS:0028041607

SN - 0019-509X

VL - 31

SP - 1

EP - 7

JO - Indian Journal of Cancer

JF - Indian Journal of Cancer

IS - 1

ER -

Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this